Today: 8 February 2026
Subscribe
Browse Category

Stock Market News 9 December 2025

NextEra Energy (NEE) Stock on December 9, 2025: Google Cloud AI Grid Deal, Price Action and Analyst Forecasts

NextEra Energy (NEE) Stock on December 9, 2025: Google Cloud AI Grid Deal, Price Action and Analyst Forecasts

NextEra Energy shares traded near $80.55 by late morning December 9, steady after a 3% drop on heavy volume the previous session. The company announced new deals with Google Cloud, Meta, and Exxon, and raised long-term earnings guidance at its New York investor day. NextEra reported Q3 adjusted EPS of $1.13, beating estimates, and declared a $0.5665 quarterly dividend. The utility operates about 76 GW of capacity across North America.
9 December 2025
···
Warner Bros. Discovery (WBD) Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Warner Bros. Discovery (WBD) Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Warner Bros. Discovery, Inc. (NASDAQ: WBD) is trading like a Hollywood cliffhanger on Tuesday, December 9, 2025. Shares are changing hands around the mid‑$27 range after jumping more than 4% intraday, extending a rally that has seen the stock climb roughly 140–150% over the past year. Smartkarma The catalyst: Paramount Skydance’s surprise all‑cash hostile bid of $30 per share, valuing Warner Bros. Discovery at about $108.4 billion including debt and directly challenging Netflix’s already‑signed $72 billion cash‑and‑stock agreement for WBD’s studios and streaming operations. Reuters+2PR Newswire+2 Below is a detailed look at the latest news, the takeover mechanics, analyst forecasts,
9 December 2025
·
Cemtrex (CETX) Stock Explodes After Reverse Split and Aerospace Pivot – What Investors Need to Know on December 9, 2025

Cemtrex (CETX) Stock Explodes After Reverse Split and Aerospace Pivot – What Investors Need to Know on December 9, 2025

Cemtrex shares surged 130% Monday to close at $7.05 after wild trading, then dropped about 14% in Tuesday pre-market. The move follows a series of reverse stock splits and a November deal to acquire aerospace firm Invocon for $7.06 million. Cemtrex’s market value remains near $5 million, with a 52-week range of $2.50 to $57.75.
9 December 2025
··
Sezzle Inc (SEZL) Stock Outlook: S&P SmallCap 600 Inclusion, Earnings Surge and Price Forecast

Sezzle Inc (SEZL) Stock Outlook: S&P SmallCap 600 Inclusion, Earnings Surge and Price Forecast

Sezzle Inc. will join the S&P SmallCap 600 index on December 15, replacing Vital Energy, S&P Dow Jones Indices said December 8. Sezzle shares closed at $67.70, up 6–8% in after-hours trading after the announcement. The company posted Q3 net income of $26.7 million on $116.8 million revenue, both up sharply year over year. Sezzle’s market cap stands at about $2.3 billion.
9 December 2025
··
‘Superflu’ H3N2 K-Strain: Symptoms, Vaccine Protection and How the New Flu Variant Is Hitting Hospitals This Winter

‘Superflu’ H3N2 K-Strain: Symptoms, Vaccine Protection and How the New Flu Variant Is Hitting Hospitals This Winter

A/H3N2 subclade K, known as the “K-strain,” now makes up about 90% of flu samples in the UK and Japan and has been found on every continent. NHS leaders in London report hospital flu admissions have tripled from last year, with no sign of a peak. Early data indicate this season’s flu vaccine remains strongly protective against severe illness.
9 December 2025
UK Stock Market Movers Today (9 December 2025): Most‑Active FTSE 100 Stocks and What’s Driving Them

UK Stock Market Movers Today (9 December 2025): Most‑Active FTSE 100 Stocks and What’s Driving Them

The FTSE 100 closed nearly flat at 9,650 on December 9, 2025, as traders awaited a US Federal Reserve decision. Trading volumes were heavy in Lloyds, Legal & General, Glencore, Vodafone, Barclays, Tesco, BP, BT, Rolls-Royce, Magnum Ice Cream, and British American Tobacco. Unilever’s ice-cream spin-off and strong bank shares featured among the session’s main themes.
9 December 2025
··
UK Stock Market Top Losers Today (9 December 2025): BAT Leads FTSE 100 Fallers as Unilever Hangover Lingers

UK Stock Market Top Losers Today (9 December 2025): BAT Leads FTSE 100 Fallers as Unilever Hangover Lingers

The UK stock market spent Tuesday, 9 December 2025, in a cautious mood, with a handful of big names doing most of the damage. The FTSE 100 slipped around 0.1% to roughly 9,640, its lowest close in about two weeks, as investors positioned for a crucial Federal Reserve decision and another Bank of England rate call. TradingView+1 While the index is still hovering near record highs for 2025, British American Tobacco, Chemring and Ashtead were among the standout losers today, and Monday’s sharp falls in Unilever, Barratt Redrow, JD Sports Fashion, Persimmon and Entain are still shaping sentiment. TechStock²+1 Market snapshot: Cautious FTSE 100, weak consumers Two
9 December 2025
··
UK Stock Market Today: Unilever, WPP, Babcock, Trustpilot and Ocado Lead Top Gainers on 9 December 2025

UK Stock Market Today: Unilever, WPP, Babcock, Trustpilot and Ocado Lead Top Gainers on 9 December 2025

Unilever shares jumped 13.1% in London after the company completed the spin-off of its ice cream business and a share consolidation. The FTSE 100 closed up 0.08% at 9,653.19, while the FTSE 250 rose 0.17%. WPP, Babcock, Trustpilot, Ocado, Helios Towers, Man Group, and Moonpig also posted strong gains. European markets edged higher as investors awaited the US Federal Reserve meeting.
9 December 2025
·
Structure Therapeutics (NASDAQ: GPCR) Stock Explodes on Obesity Pill Data and $500M Offering: Latest News and Forecasts as of December 9, 2025

Structure Therapeutics (NASDAQ: GPCR) Stock Explodes on Obesity Pill Data and $500M Offering: Latest News and Forecasts as of December 9, 2025

Structure Therapeutics shares closed at $69.98 on December 9, 2025, up 102% after positive Phase 2b trial results for its oral obesity drug aleniglipron. The stock hit a new 52-week high of $94.90 intraday, pushing market value to $4.25 billion. The company announced a $500 million equity offering following the surge. Aleniglipron showed up to 15.3% placebo-adjusted weight loss in studies.
9 December 2025
··
AMD Stock on December 9, 2025: AI Supercomputers, OpenAI Deal and Wall Street Targets in Focus

AMD Stock on December 9, 2025: AI Supercomputers, OpenAI Deal and Wall Street Targets in Focus

AMD shares traded near $221 on Tuesday, up 190% from their 52-week low but 17% below their high. Q3 2025 revenue reached $9.25 billion, beating estimates, with data center sales up 22% and PC chip revenue up 46% year over year. The company guided Q4 revenue to about $9.6 billion. AMD’s market cap stands in the mid-$300 billion range.
9 December 2025
···
Procter & Gamble (PG) Stock Hits Two‑Year Low as CFO Sounds Alarm on U.S. Consumer – What It Means for Investors Now

Procter & Gamble (PG) Stock Hits Two‑Year Low as CFO Sounds Alarm on U.S. Consumer – What It Means for Investors Now

Procter & Gamble shares fell to about $138 on December 9, 2025, down 23% from their 52-week high and near a two-year low after an analyst downgrade and cautious outlook from management. CFO Andre Schulten warned of a “more volatile” U.S. consumer environment, with significant declines in category volume and value in October and November.
9 December 2025
·
Exicure (XCUR) Stock Soars on Burixafor Phase 2 Data: What December 2025 Investors Need to Know

Exicure (XCUR) Stock Soars on Burixafor Phase 2 Data: What December 2025 Investors Need to Know

Exicure shares surged over 100% in pre-market trading December 9 after reporting positive topline Phase 2 results for burixafor in multiple myeloma at the ASH meeting. The trial met its primary endpoint in 17 of 19 patients, with no serious drug-related adverse events. XCUR closed at $5.33 on December 8, up 8.78%, and traded as high as $10.84 pre-market, pushing market cap to around $30–40 million.
9 December 2025
··
Biggest Stock Gainers Today in the US (Dec. 9, 2025): Wave Life Sciences, Structure Therapeutics, Confluent and More

Biggest Stock Gainers Today in the US (Dec. 9, 2025): Wave Life Sciences, Structure Therapeutics, Confluent and More

Wave Life Sciences shares jumped about 147% Monday after positive data on its experimental RNA obesity drug, leading US stock gainers. The Dow fell 0.45%, S&P 500 lost 0.35%, and Nasdaq slipped 0.14% as investors awaited Wednesday’s Federal Reserve decision. Nvidia rose after the US allowed exports of its H200 AI chips to China with a 25% fee.
9 December 2025
····
Most Active Stocks Today (December 9, 2025): Nvidia, Tesla, Wave Life Sciences and Confluent Lead a Fed-Focused Wall Street

Most Active Stocks Today (December 9, 2025): Nvidia, Tesla, Wave Life Sciences and Confluent Lead a Fed-Focused Wall Street

Nvidia and AI chip stocks led US trading volumes Monday after the Biden administration cleared Nvidia’s H200 chips for export to China, with the government taking a 25% revenue cut. The S&P 500, Dow, and Nasdaq all closed just below record highs. Investors await the Fed’s final 2025 policy decision, with markets expecting a third rate cut this year. Treasury yields and the dollar held steady.
9 December 2025
····
Air Products (APD) Stock Hits 52‑Week Low After Yara Hydrogen Deal: What the Latest Drop Means for 2026

Air Products (APD) Stock Hits 52‑Week Low After Yara Hydrogen Deal: What the Latest Drop Means for 2026

Air Products shares plunged about 9% to a 52-week low near $235 on December 9 after revealing advanced talks with Yara on major low-emission ammonia projects in Louisiana and Saudi Arabia. The stock is now down roughly 18% year to date and 25% over the past 12 months. Most analysts still rate APD a “Buy” with a 12-month price target near $305–315.
9 December 2025
·
Octopus Energy Stock in 2025: ORIT Share Price, 10% Yield and Kraken’s $15 Billion Spin‑Off Explained

Octopus Energy Stock in 2025: ORIT Share Price, 10% Yield and Kraken’s $15 Billion Spin‑Off Explained

Octopus Energy Group remains privately owned; the publicly traded Octopus Renewables Infrastructure Trust (LON: ORIT) is often mistaken for “Octopus Energy stock.” On 9 December 2025, ORIT traded near 59.2p, about 40% below its latest reported NAV of 98.46p. Kraken, Octopus’s software arm, is being spun off with a targeted $15 billion valuation and possible IPO within a year.
9 December 2025
··
Biggest Stock Losers Today on the U.S. Market (Dec. 9, 2025 Update)

Biggest Stock Losers Today on the U.S. Market (Dec. 9, 2025 Update)

Air Products & Chemicals shares plunged over 9% Monday, the worst drop in the S&P 500, after the company revealed talks with Yara International on a multibillion-dollar ammonia partnership. The Dow fell about 0.5% to 47,739, S&P 500 lost 0.4% to 6,846, and Nasdaq slipped 0.2%. Ten of eleven S&P 500 sectors declined as investors awaited Wednesday’s Federal Reserve rate decision.
9 December 2025
·
Stock Market Today: Dow Jones, S&P 500 and Nasdaq Eye Rebound as Fed Rate Cut and Nvidia China Deal Drive Wall Street — December 9, 2025

Stock Market Today: Dow Jones, S&P 500 and Nasdaq Eye Rebound as Fed Rate Cut and Nvidia China Deal Drive Wall Street — December 9, 2025

US stock futures are pointing to a cautiously higher open on Tuesday, December 9, 2025, as Wall Street digests a modest pullback from record territory and looks ahead to a pivotal Federal Reserve meeting and a major policy shift on AI chips. After the S&P 500, Dow Jones Industrial Average and Nasdaq Composite all slipped on Monday, they remained just below all‑time highs, setting the stage for a key “Fed week” that could define the year’s final stretch.Reuters+ 2KPRC+ 2 Investors are overwhelmingly expecting the Fed to deliver a quarter‑point rate cut on Wednesday — the third cut this year
9 December 2025
···
1 … 853 854 855 856 857 … 1,179

Stock Market Today

RELX share price slides again on AI worries; what to watch ahead of Feb 12 results

RELX share price slides again on AI worries; what to watch ahead of Feb 12 results

8 February 2026
RELX shares fell 4.6% to 2,145p on Friday, near a 52-week low, despite the FTSE 100 closing higher. The company disclosed a new buyback of 465,361 shares on Feb. 6 and has repurchased over 8.8 million shares since Jan. 2. Investors await RELX’s full-year 2025 results on Feb. 12 amid concerns over AI’s impact on its core business.
Glencore shares steady after Rio walks away — what to watch before Monday’s trade

Glencore shares steady after Rio walks away — what to watch before Monday’s trade

8 February 2026
Glencore shares closed up 0.6% at 478.10 pence Friday after Rio Tinto ended merger talks, issuing a “no intention to bid” statement. Glencore’s board rejected the proposed deal terms, citing concerns over valuation and governance. Attention now turns to possible asset sales, including its $5 billion Kazzinc stake, ahead of Glencore’s annual results on Feb. 18.
Go toTop